Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Case of Eosinophilic Fasciitis Presenting with Pansclerotic Morphea

Julia K. Munchel, MD, & William E. Monaco, MD  |  Issue: May 2019  |  May 17, 2019

Eosinophilic fasciitis generally presents with the acute onset of edema followed by progressive skin induration in the setting of hypergammaglobulinemia, an elevated erythrocyte sedimentation rate (ESR) and peripheral eosinophilia in 63–93% of patients.1,2 Skin involvement is typically limited to 20.1% of total body surface area and most commonly involves the extremities symmetrically.1,3

The condition was first described by Lawrence E. Shulman, MD, PhD, in 1974, but despite being a known entity for almost 50 years, no generally accepted diagnostic criteria exist today. The current gold standard for diagnosis remains a full-thickness skin biopsy.4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In one study, 79% of patients with eosinophilic fasciitis were found to be misdiagnosed, most commonly with systemic sclerosis.2 This mistake is likely due to the fact that 30–50% of patients with eosinophilic fasciitis have concomitant morphea plaques.1,2 However, eosinophilic fasciitis can be distinguished from scleroderma largely by a lack of Raynaud’s phenomenon, normal nailfold capillaroscopy and the absence of visceral organ involvement.1

We present the case of a middle-aged woman who developed diffuse, pansclerotic morphea. Her condition was initially diagnosed as scleromyxedema based on skin biopsy, and she was treated unsuccessfully with intravenous immunoglobulin (IVIG) until a full-thickness skin biopsy 10 months later demonstrated bands of fibrosis consistent with eosinophilic fasciitis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case Summary

A 55-year-old woman presented at our facility with complaints of shortness of breath and swelling of her face, throat, hands and feet. Her past medical history included ulcerative colitis with no flare despite a decade off of all medications. She had hypertension and hypothyroidism, which were well controlled on levothyroxine. The surgical and family history were non-contributory. Her social history was significant for years of exposure to a wood-stripping agent.

The patient believed her illness had begun eight months earlier when she first presented to her primary care provider with several, non-painful, enlarged cervical lymph nodes, odynophagia, fatigue and, later, generalized body swelling.

The outpatient workup was unrevealing, and before a lymph node biopsy could be performed, repeat imaging demonstrated resolution of the patient’s lymphadenopathy. During the primary care workup, she was treated with diuretics, as well as prednisone, without symptomatic improvement, and she had stopped these medications prior to presentation at our facility.

Evidence of the patient’s small oral aperture at the time of presentation.

Figure 1. Evidence of the patient’s small oral aperture at the time of presentation.

Figure 2. The prayer sign, which is rarely seen in patients suffering from eosinophilic fasciitis.

Figure 2. The prayer sign, which is rarely seen in patients suffering from eosinophilic fasciitis.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Sclerosis Tagged with:eosinophilic fasciitispansclerotic morphea

Related Articles
    Kamolrat/SHUTTERSTOCK.COM

    Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists

    June 15, 2015

    Clinical Vignette A 45-year-old woman with long-standing asthma and chronic sinusitis has new-onset peripheral neuropathy, arthralgias, fatigue, progressive dyspnea and a nonproductive cough. She has never smoked and has no environmental exposures. Her medications include an albuterol metered-dose inhaler (which she uses daily); an inhaled corticosteroid, montelukast; and ibuprofen (which she takes occasionally). She is…

    Study Probes New Gene Therapy for Severe, Localized Scleroderma (Morphea)

    August 16, 2019

    In September 2018, the U.S. Food & Drug Administration (FDA) granted fast-track status to FCX‑013, a gene therapy product developed to treat moderate to severe localized scleroderma (morphea). Previously, the treatment received an orphan drug designation for localized scleroderma, as well as a rare pediatric disease designation. Phase 1 and 2 studies will assess safety…

    Figures 1 & 2: On exam, the patient had thickening of the skin on her extremities.

    Dermatology Symptoms Point to Connective Tissue Disorder

    May 15, 2015

    The Case A 68-year-old woman with a past medical history of Charcot-Marie-Tooth presents with thickening of the skin on her trunk and extremities, which she has had for the past seven months (see Figures 1 and 2). Her symptoms first began with swelling of her bilateral upper and lower extremities. She is now having difficulty…

    Fellows’ Forum Case Report: Palmar Fasciitis & Polyarthritis Syndrome

    November 16, 2015

    Case report: A 78-year-old Caucasian female presented to our outpatient rheumatology clinic with pain in her bilateral shoulders, hands and knees that began suddenly one month earlier. She admitted to stiffness in her hands lasting several hours, and expressed an inability to extend her fingers. She denied fever, rashes, jaw claudication, headache or visual changes….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences